Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Genetic Diseases, Inborn × Clinical Trials, Phase II as Topic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Multiple Myeloma 1 Genetic Diseases, Inborn 1

Interventions

Melphalan 3 thymoglobulin 1 sargramostim 1 romidepsin 1 keyhole-limpet hemocyanin 1 ixazomib 1 Thalidomide 1 Tablets 1 Streptozocin 1 Radiosurgery 1 Radiation 1 Mercaptopurine 1 Leucovorin 1 Ketoconazole 1 Fulvestrant 1 Floxuridine 1 FANG vaccine 1 Docetaxel 1 Clinical Trials, Phase II as Topic 1 Carmustine 1 Antilymphocyte Serum 1 Alpelisib 1 Alendronate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03683277 2025-02-19

IFM2014-01

Intergroupe Francophone du Myelome

Phase 2 Terminated

Multiple Myeloma, Recurrence, Genetic Diseases, Inborn

Data powered by HemOnc (CC BY 4.0) Colophon ⚡